Dyno Therapeutics is a company based in Cambridge, Massachusetts applying artificial intelligence to gene therapy, focused on adeno-associated virus capsid engineering.
Dyno Therapeutics raised $9M in Seed round funding on May 11, 2020. Lead investors were Polaris Partners & CRV.